• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MYX

MAYNE PHARMA GROUP LIMITED - News & Media

2.59% ! $5.15
Market Cap $418.4M  !

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$5.15
Change
0.130(2.59%)
Mkt cap ! $418.4M
Open High Low Value Volume
$5.05 $5.17 $5.05 $571.9K 111.9K

Buyers (Bids)

No. Vol. Price($)
1 5000 $5.03
 

Sellers (Offers)

Price($) Vol. No.
$5.17 490 1
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.